These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1862734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK, Mellergård M, Rosenberg R, Beck P, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():33-8. PubMed ID: 1862732
    [Abstract] [Full Text] [Related]

  • 6. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Nov; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patterns of response during placebo treatment of panic disorder.
    Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [Abstract] [Full Text] [Related]

  • 12. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
    Rickels K, Schweizer E, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
    [Abstract] [Full Text] [Related]

  • 15. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W, Albus M, Buller R, Nutzinger D, Shera D, Bech P.
    Eur Arch Psychiatry Clin Neurosci; 1990 Jan; 240(2):103-8. PubMed ID: 2149648
    [Abstract] [Full Text] [Related]

  • 16. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 17. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Jan; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 18. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 19. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 20. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.